- Alcon Elevates Vitreoretinal and Cataract Surgery for Superior Efficiency* with UNITY VCS and UNITY CS
- Intensity Therapeutics, Inc. Announces $2.35 Million Public Offering
- Carr Tech Corp Celebrates FDA 510(k) Class II Approval of FROG All-in-One Filter Needle
- Veracyte Announces Expanded Availability of Decipher Prostate Test to Patients with Metastatic Prostate Cancer
- Second Phase of ADVANTAGE AF study of FARAPULSE ™ Pulsed Field Ablation System Meets Primary Safety and Efficacy Endpoints
- Overture Life Secures $57M in Total Funding | Earns U.S. CLIA License to Deliver Reliable, Scalable IVF Automation
- CorWave Completes 6-Month In Vivo Study for Clinical Trials Initiation
Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States
Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!
Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook
HR Pharmaceuticals Receives Exclusive Commercialization Rights to Poiesis Medical’s Dual Balloon Catheter Technology in No America
The Dual Balloon Catheter has demonstrated significant benefits compared to traditional Foley catheters, leading to better patient outcomes. Specifically, we see a great opportunity for patients requiring indwelling catheterization greater than five days. This product will become an important part of our broader urology strategy over the next 12 months,” states Colby Wiesman, President of HR Pharmaceuticals, Inc.
Wandong Medical Reports: Full-line Products Obtain the MDR Certification, Facilitating Its Entry to the European Market
The MDR certification acts as a catalyst for Wandong Medical to expand its coverage in the international market, accelerate the process of globalization, and contribute Chinese solutions to the health of people around the world.
Inspira Technologies Collaborates with Ennocure for development of a Proprietary Bio-Electronic Treatment to Prevent Associated Bloodstream Infections in ICU Patients
Dagi-Ben Noon, CEO of Inspira Technologies, reflects on the partnership’s significance: “By Integrating our technology to oxygenate blood directly with Ennocure’s infection prevention solutions, we are focusing on potentially improving patient outcomes in ICUs and paving the way for safer, more effective life-support treatments. This collaboration is expected to accelerate the development and broaden the implementation of our advanced technology.”
MolecuLight Reports United States Patent and Trademark Office Cancels All Claims of Swift Medical’s Patent
The decision cancels each of the original claims of the ‘345 Patent and declares unpatentable each of Swift’s proposed substitute claims. Amongst the prior art deemed by the USPTO to render the ‘345 Patent unpatentable is a patent application licensed to MolecuLight that lists MolecuLight’s Founder, Dr. Ralph DaCosta, as the sole inventor.
Clinical Trials
New Data Presented at CHEST 2023 Demonstrate the Clinical Utility of Veracyte’s Envisia Genomic Classifier for Patients with Interstitial Lung Disease
The studies presented at the CHEST Annual Meeting show that adding the Envisia Genomic Classifier to the diagnostic process can improve the ability to detect UIP.
Owlstone Medical Recruits First Patient in Phase 2 Clinical Trial for the Early Detection of Lung Cancer through Breath Biopsy
Billy Boyle, co-founder and CEO at Owlstone Medical, said: “Results from Phase 1 of the EVOLUTION trial demonstrated the relevance of the molecular pathway targeted by D5-EthGlu and provided crucial evidence to support further test development. With the recruitment of the first patient into Phase 2, we are excited to continue to progress a test that has the potential to transform lung cancer diagnosis by substantially increasing the uptake of testing, leading to more cases of lung cancer being caught early and significantly reducing mortality and costs. Our nodule management test also holds the potential for more effective identification of benign nodules, reducing unnecessary biopsies and surgery.”
Salubris Biotherapeutics Presents Positive 6-Month Data from Phase 1b Clinical Trial of JK07 in Late-Breaking Session at The Heart Failure Society of America Annual Meeting 2023
The data were presented in a late breaking oral session during the Heart Failure Society of America Annual Scientific Meeting 2023. JK07 is the first investigational antibody fusion protein and first selective ErbB4 agonist to enter clinical development for heart failure. Heart failure is a leading cause of morbidity and mortality globally, with estimates of more than 6 million patients affected by HFrEF and HFpEF in the US.
Biotechnology News
Our Experts – Byline Articles
Read Their Views & Share With a Colleague or Two!
FDA Medical Device Updates
Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding
Inomagen Therapeutics Awarded $1.6 million NIH SBIR Phase 2 Grant
Proceeds from the award will be utilized to continue the advancement of the company’s novel gene therapy for the treatment of atrial fibrillation (AF), the world’s most common arrythmia.
Bluegrass Vascular Closes $5 Mil Convertible Debt Financing
Funding will support the acceleration of the commercial expansion of Bluegrass Vascular’s Surfacer® System.
Ceros Financial Services Arranges $15MM Financing for Pristine Surgical
“Pristine Surgical has brought the endoscope into the 21st Century, improving the endoscopic procedure for both patient and surgeon,” said Mark Goldwasser, CEO of Ceros Financial Services.
Saluda Medical Announces $125M Equity Financing
Net proceeds from the financing will be used to operationalize and scale commercialization of the Evoke® Spinal Cord Simulation System (SCS) for chronic pain.
Market Reports
Advancements in Imaging
Hospitals In the News
Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry
Non-Profit News
Healthcare - Understanding the Business Side of the Industry and Its Implications
Mastering the Art of Writing for Medical Journals and Publications
Some authors find it demanding to prepare a flawless paper for medical journals. Here is an outlook on some tips writers can follow to master the art of writing for prestigious and trustworthy publications.
5 Efficient and Top EHR Software for Impactful Healthcare Treatment!
Here is a list of five efficient and top EHR choices preferred by the majority of practitioners for impactful healthcare treatment. Get the details for picking the best EHR software!
3 Crucial Roles of Leadership in Forging Effective Communication Among Remote Tech Teams
As more businesses and companies embrace the flexibility that comes with employees working remotely and in person, more specific technology companies. It is without a
A Brief Overview Of Healthcare Cybersecurity
Cybersecurity is a paramount concern for the healthcare sector – especially in light of recent cyberattacks and data breaches. In addition to being home to